PM - PM MPC among premarket gainers September, 25 2019 09:17 AM Philip Morris International Inc PhaseBio Pharmaceuticals (NASDAQ:PHAS) +21% on end of PB2452 trial.More news on: PhaseBio Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., Philip Morris International Inc., Stocks on the move, Read more ...